Clinical and sociodemographic correlates of severe insomnia in psychotropic drug-free, Asian outpatients with major depressive disorder

被引:14
|
作者
Srisurapanont, Manit [1 ]
Likhitsathian, Surinporn [1 ]
Chua, Hong Choon [2 ]
Udomratn, Pichet [3 ]
Chang, Sungman [4 ]
Maneeton, Narong [1 ]
Maneeton, Benchaluk [1 ]
Chen, Chia-Hui [5 ]
Chan, Edwin Shih-Yen [6 ,7 ]
Bautista, Dianne [6 ,7 ]
Sulaiman, Ahmad Hatim Bin [8 ]
机构
[1] Chiang Mai Univ, Fac Med, Dept Psychiat, Chiang Mai 50200, Thailand
[2] Woodbridge Hosp, Inst Mental Hlth, Singapore, Singapore
[3] Prince Songkla Univ, Fac Med, Dept Psychiat, Hat Yai, Thailand
[4] Kyungpook Natl Univ Hosp, Dept Psychiat, Daegu, South Korea
[5] Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, Nat Hlth Res Inst, Taipei, Taiwan
[6] Duke NUS Grad Med Sch, Singapore, Singapore
[7] Singapore Clin Res Inst, Singapore, Singapore
[8] Univ Malaya, Dept Psychol Med, Kuala Lumpur, Malaysia
关键词
Asian; Insomnia; Depressive disorders; SCL-90-R; Subjective; QUALITY-OF-LIFE; RECURRENT FALLS; SYMPTOMS; ANTIDEPRESSANTS; SCALE; EPIDEMIOLOGY; PREVALENCE; PREDICTORS; RISK;
D O I
10.1016/j.jad.2015.06.032
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Little has been known regarding the correlates of severe insomnia in major depressive disorder (MDD). This post-hoc analysis aimed to examine the sociodemographic and clinical correlates of severe insomnia in psychotropic drug free, Asian adult outpatients with MDD. Methods: Participants were psychotropic drug-free patients with MDD, aged 18-65 years. By using the Symptom Checklist 90 Items, Revised (SCL-90-R), a score of 4 (severe distress) on any one of three insomnia items was defined as severe insomnia. Other measures included the Montgomery-Asberg Depression Rating Scale (MADRS), the Fatigue Severity Scale (FSS), the nine psychopathology subscales of SCL-90-R, the Physical and Mental Component Summaries of Short Form Health Survey (SF 36 PCS and SF 36 MCS), and the Sheehan Disability Scale (SDS). Results: Of 528 participants, their mean age being 39.5 (SD=1326) years, 64.2% were females, and 239 (45.3%) had severe insomnia. The logistic regression model revealed that low educational qualifications (less than secondary school completion), high SCL-90-R Depression scores, high SCL-90-R Anxiety scores, and low SF 36 PCS scores were independently correlated with severe insomnia (p's < .05). Limitations: Insomnia was determined only by the patient's distress. Middle insomnia was not assessed. Psychotropic drug free patients with MDD are not commonly seen in psychiatric practice. Conclusion: Severe insomnia is common in patients with MDD. It is closely related with low educational qualification, subjective depression and anxiety severity, and poor physical health. These findings may implicate the treatment of comorbid MDD and severe insomnia, for example, sleep hygiene education, pharmacological treatment. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:26 / 31
页数:6
相关论文
共 50 条
  • [1] Clinical and sociodemographic correlates of severe insomnia in psychotropic drug-free, adult outpatients with major depressive disorder
    Srisurapanont, M.
    Likhitsathian, S.
    Chua, H. C.
    Udomratn, P.
    Chang, S.
    Maneeton, N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S385 - S385
  • [2] Clinical and sociodemographic correlates of anxiety symptoms in psychotropic drug-free, Asian outpatients with major depressive disorder
    Suttajit, S.
    Maneeton, N.
    Maneeton, B.
    Likhitsathian, S.
    Eurviyanukul, K.
    Udomratn, P.
    Srisurapanont, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S412 - S413
  • [3] Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries
    Ah-Young Lim
    Ah-Rong Lee
    Ahmad Hatim
    Si Tian-Mei
    Chia-Yih Liu
    Hong Jin Jeon
    Pichet Udomratn
    Dianne Bautista
    Edwin Chan
    Shen-Ing Liu
    Hong Choon Chua
    Jin Pyo Hong
    BMC Psychiatry, 14
  • [4] Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries
    Lim, Ah-Young
    Lee, Ah-Rong
    Hatim, Ahmad
    Tian-Mei, Si
    Liu, Chia-Yih
    Jeon, Hong Jin
    Udomratn, Pichet
    Bautista, Dianne
    Chan, Edwin
    Liu, Shen-Ing
    Chua, Hong Choon
    Hong, Jin Pyo
    BMC PSYCHIATRY, 2014, 14
  • [5] Clinical and socio-demographic correlates of anxious distress in Asian outpatients with major depressive disorder
    Maneeton, Narong
    Suttajit, Sirijit
    Maneeton, Benchalak
    Likhitsathian, Surinporn
    Eurviyanukul, Kanokkwan
    Udomratn, Pichet
    Chan, Edwin Shih-Yen
    Si, Tian-Mei
    Sulaiman, Ahmad Hatim
    Chen, Chia-Hui
    Bautista, Dianne
    Srisurapanont, Manit
    NORDIC JOURNAL OF PSYCHIATRY, 2017, 71 (07) : 503 - 508
  • [6] Neurocognitive impairment in drug-free patients with major depressive disorder
    Porter, RJ
    Gallagher, P
    Thompson, JM
    Young, AH
    BRITISH JOURNAL OF PSYCHIATRY, 2003, 182 : 214 - 220
  • [7] Platelet 5-HT1A receptor correlates with major depressive disorder in drug-free patients
    Zhang, Zhang-Jin
    Wang, Di
    Man, Sui Cheung
    Ng, Roger
    McAlonan, Grainne M.
    Wong, Hei Kiu
    Wong, Wendy
    Lee, Jade
    Tan, Qing-Rong
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2014, 53 : 74 - 79
  • [8] Separation anxiety disorder among outpatients with major depressive disorder: Prevalence and clinical correlates
    Elbay, Rumeysa Yeni
    Gormez, Aynur
    Kilic, Alperen
    Avci, Selma Hilal
    COMPREHENSIVE PSYCHIATRY, 2021, 105
  • [9] Discovery of serum protein biomarkers in drug-free patients with major depressive disorder
    Kim, Eun Young
    Ahn, Yong Min
    Baik, Myung Jae
    Lee, Min Young
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 118 - 118
  • [10] Discovery of serum protein biomarkers in drug-free patients with major depressive disorder
    Lee, Min Young
    Kim, Eun Young
    Kim, Se Hyun
    Cho, Kyung-Cho
    Ha, Kyooseob
    Kim, Kwang Pyo
    Ahn, Yong Min
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2016, 69 : 60 - 68